luzindole has been researched along with 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one in 1 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) | Trials (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) | Recent Studies (post-2010) (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 793 | 0 | 110 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genade, S; Genis, A; Huisamen, B; Lochner, A; Ytrehus, K | 1 |
1 other study(ies) available for luzindole and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
| Article | Year |
|---|---|
Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions.
Topics: Adrenergic Antagonists; Animals; Colforsin; Cyclic AMP; Guanylate Cyclase; Heart; Indoles; Isoproterenol; Male; Maleimides; Melatonin; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxadiazoles; p38 Mitogen-Activated Protein Kinases; Propranolol; Protein Kinase C; Quinoxalines; Rats; Rats, Wistar; Receptors, Melatonin; Tryptamines | 2008 |